Keyword: mAb

Improving ADC Production and Purification

Lonza AG -

How Optimizing Process Parameters Can Improve Scalability and Manufacturability of a Cytotoxic Antibody Drug Conjugate.

Cerbios' new State-of the-art R&D Centre for HPAI and mAb Development

21.09.2016 - On February 15th, 2016, Cerbios Pharma officially opened its new R&D Centre in Lugano, Switzerland. During the past 15 years, Cerbios has heavily invested in infrastructures, in...

Plant Construction & Process Technology

Flexibility in Bioprocessing

11.05.2011 - It was a most unusual road trip - Drivers on the highways of Europe were probably surprised to see the scaled-down equivalent of a bioprocessing production line rolling next to...